The Impact of COVID-19
on Clinical Research

 

CLICK TO LEARN MORE

What is the

Heart Failure Collaboratory (HFC)?

Efficiency of clinical trials and evidence generation in heart failure and foster development of therapies by creating a collaborative environment in which FDA, government agencies including NIH and CMS, and the heart failure community can interact to optimize innovation and advancement of new therapeutic products. HFC has established five working groups to tackle individual issues in clinical trials and fostering the development of effective heart failure therapies.


The Heart Failure Collaboratory is a public-private partnership with the FDA and the consortium to help foster the development of new products for heart failure.

Follow us on Twitter

HAPPENING NOW—HFC Statistical Concepts for HF Drug and Device Development: The Impact of COVID! Phenomenal expert panel engaging in important discussions! #heartfailure #clinicaltrials

What an extraordinary meeting @hfcollaboratory !
Can't wait to see the conclusions that come out of this... 🤯

@mpsotka @coconnormd @robmentz @mfiuzat @JEPomeroyMDPhD

2
Load More...

Recent Publications

Access our latest publications, downloads and meeting notes.
Use of Actigraphy (Wearable Digital Sensors to Monitor Activity) in Heart Failure Randomized Clinical Trials: A Scoping Review
Actigraphy-based measurements of physiologic parameters may enable design of patient-centric heart failure (HF) clinical trials. Recently, the Heart Failure Collaboratory focused on recommendations for meaningful change and use of actigraphy as an end point in HF clinical trials.
Promoting Diversity in Clinical Trial Leadership: A Call to Action
As a community of investigators, we have struggled to improve the recruitment of representative populations into heart failure (HF) trials.
Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19
The purpose of this study was to evaluate in-hospital outcomes among patients with a history of heart failure (HF) hospitalized with coronavirus disease-2019 (COVID-19).